dasatinib

Generic: dasatinib

Labeler: zydus lifesciences limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name dasatinib
Generic Name dasatinib
Labeler zydus lifesciences limited
Dosage Form TABLET
Routes
ORAL
Active Ingredients

dasatinib 70 mg/1

Manufacturer
Zydus Lifesciences Limited

Identifiers & Regulatory

Product NDC 70771-1903
Product ID 70771-1903_571889d7-845d-4fed-8d7d-6470d4d36fa1
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA218719
Listing Expiration 2026-12-31
Marketing Start 2025-03-03

Pharmacologic Class

Classes
cytochrome p450 3a4 inhibitors [moa] kinase inhibitor [epc] protein kinase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 707711903
Hyphenated Format 70771-1903

Supplemental Identifiers

RxCUI
643105 643107 643109 799047 1045402 1045406
UPC
0370710174439 0370710174163 0370710174262 0370710174637 0370710174361 0370710174538
UNII
RBZ1571X5H

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name dasatinib (source: ndc)
Generic Name dasatinib (source: ndc)
Application Number ANDA218719 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 70 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (70771-1903-6)
source: ndc

Packages (1)

70771-1903-6 60 TABLET in 1 BOTTLE (70771-1903-6)

Ingredients (1)

dasatinib (70 mg/1)

Linked Drug Pages (1)

dasatinib ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "571889d7-845d-4fed-8d7d-6470d4d36fa1", "openfda": {"upc": ["0370710174439", "0370710174163", "0370710174262", "0370710174637", "0370710174361", "0370710174538"], "unii": ["RBZ1571X5H"], "rxcui": ["643105", "643107", "643109", "799047", "1045402", "1045406"], "spl_set_id": ["4eed6b7b-a09d-4d2e-a345-968dd68323bc"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (70771-1903-6)", "package_ndc": "70771-1903-6", "marketing_start_date": "20250303"}], "brand_name": "dasatinib", "product_id": "70771-1903_571889d7-845d-4fed-8d7d-6470d4d36fa1", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "70771-1903", "generic_name": "dasatinib", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "dasatinib", "active_ingredients": [{"name": "DASATINIB", "strength": "70 mg/1"}], "application_number": "ANDA218719", "marketing_category": "ANDA", "marketing_start_date": "20250303", "listing_expiration_date": "20261231"}